Mersana announces management changes

09/29/2010 | Mass High Tech (Boston)

Mersana Therapeutics has selected Nicholas Bacopoulos, a biotech industry veteran who has been on the company's board since 2007, to serve as its president and chief executive. The company, which uses a bio-inert polymer technology in drug development, also has appointed its former CEO Julie Olson as chief technology officer.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX